Journal
Information Content Entity
Continuant
Entity
Periodical
Generically Dependent Continuant
Collection
Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters.
Trends in incidence and prevalence of HIV-1 infection in intravenous drug users
Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.
Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients
Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters
Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens
Highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.
Low prevalence of peripheral arterial disease in HIV-infected patients with multiple cardiovascular risk factors.
Prevalence and factors associated with transmitted HIV drug resistance: the role of patient characteristics and different interpretation algorithm
Lipid Abnormalities in HIV-Infected Patients and Lopinavir Plasma Concentrations
Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion
Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion
Prevalence of peripheral arterial disease in HIV-infected patients with multiple cardiovascular risk factors.
Trends in AIDS and Mortality in HIV-Infected Subjects With Hemophilia From 1985 to 2003
Low-level HIV viremia is associated with microbial translocation and inflammation.
Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors
Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain.
Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment.
Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Highly Active Antiretroviral Therapy Interruption: Predictors and Virologic and Immunologic Consequences
A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression
Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and Didanosine?
Shorter telomere length predicts poorer immunological recovery in virologically suppressed HIV-1-infected patients treated with combined antiretroviral therapy
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.
Trends in AIDS and Mortality in HIV-Infected Subjects With Hemophilia From 1985 to 2003: The Competing Risks for Death Between AIDS and Liver Disease
Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral experienced HIV-1 infected patients (CAL30001 Study)
RDF description of JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES - http://research.umh.es/vivo/pub/revista/1525-4135